Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (1-10 of 300) with videos related to

Pageof 30
Sort By:
Movement Disorders Clinical Practice|October 27, 2018
Disease-Modifying Treatments for Progressive Supranuclear PalsyMaria Stamelou, Adam L Boxer
Cell|October 17, 2023
Accelerating Alzheimer's therapeutic development: The past and future of clinical trialsAdam L Boxer, Reisa Sperling
Alzheimer Disease and Associated Disorders|December 1, 2005
Clinical features of frontotemporal dementiaAdam L Boxer, Bruce L Miller
Nature Reviews. Neurology|January 23, 2016
Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translationJulio C Rojas, Adam L Boxer
Advances in Experimental Medicine and Biology|January 12, 2021
The Frontotemporal Dementia Prevention Initiative: Linking Together Genetic Frontotemporal Dementia Cohort StudiesJonathan D Rohrer, Adam L Boxer
Seminars in Neurology|June 26, 2014
Clinical trials: past, current, and future for atypical Parkinsonian syndromesRichard M Tsai, Adam L Boxer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 26, 2024
Disentangling tau: One protein, many therapeutic approachesCourtney Lane-Donovan, Adam L Boxer
Expert Opinion on Biological Therapy|May 26, 2010
BapineuzumabGeoffrey A Kerchner, Adam L Boxer
Alzheimer Disease and Associated Disorders|December 20, 2007
Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studiesAdam L Boxer, Bradley F Boeve
Advances in Experimental Medicine and Biology|January 12, 2021
FTLD Treatment: Current Practice and Future PossibilitiesPeter A Ljubenkov, Adam L Boxer
Pageof 30

Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
Movement Disorders Clinical Practice|October 27, 2018
Disease-Modifying Treatments for Progressive Supranuclear PalsyMaria Stamelou, Adam L Boxer
Cell|October 17, 2023
Accelerating Alzheimer's therapeutic development: The past and future of clinical trialsAdam L Boxer, Reisa Sperling
Alzheimer Disease and Associated Disorders|December 1, 2005
Clinical features of frontotemporal dementiaAdam L Boxer, Bruce L Miller
Nature Reviews. Neurology|January 23, 2016
Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translationJulio C Rojas, Adam L Boxer
Advances in Experimental Medicine and Biology|January 12, 2021
The Frontotemporal Dementia Prevention Initiative: Linking Together Genetic Frontotemporal Dementia Cohort StudiesJonathan D Rohrer, Adam L Boxer
Seminars in Neurology|June 26, 2014
Clinical trials: past, current, and future for atypical Parkinsonian syndromesRichard M Tsai, Adam L Boxer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 26, 2024
Disentangling tau: One protein, many therapeutic approachesCourtney Lane-Donovan, Adam L Boxer
Expert Opinion on Biological Therapy|May 26, 2010
BapineuzumabGeoffrey A Kerchner, Adam L Boxer
Alzheimer Disease and Associated Disorders|December 20, 2007
Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studiesAdam L Boxer, Bradley F Boeve
Advances in Experimental Medicine and Biology|January 12, 2021
FTLD Treatment: Current Practice and Future PossibilitiesPeter A Ljubenkov, Adam L Boxer
Pageof 30